Equities

Avadel Pharmaceuticals PLC

Avadel Pharmaceuticals PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)13.60
  • Today's Change-0.05 / -0.37%
  • Shares traded1.09m
  • 1 Year change+16.84%
  • Beta1.5206
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments10596157
Total Receivables, Net132.5932
Total Inventory10----
Prepaid expenses5.291.753.45
Other current assets, total------
Total current assets134101192
Property, plant & equipment, net3.182.552.94
Goodwill, net171717
Intangibles, net------
Long term investments------
Note receivable - long term0.331.231.23
Other long term assets10119.65
Total assets165133247
LIABILITIES
Accounts payable117.897.68
Accrued expenses259.9413
Notes payable/short-term debt000
Current portion long-term debt/capital leases038--
Other current liabilities, total0.260.290.57
Total current liabilities375621
Total long term debt092142
Total debt0129142
Deferred income tax------
Minority interest------
Other liabilities, total406.525.62
Total liabilities77154169
SHAREHOLDERS EQUITY
Common stock0.900.630.59
Additional paid-in capital855590549
Retained earnings (accumulated deficit)(745)(585)(448)
Treasury stock - common------
Unrealized gain (loss)0.95(1.89)(0.09)
Other equity, total(24)(24)(24)
Total equity88(21)78
Total liabilities & shareholders' equity165133247
Total common shares outstanding906359
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.